|
There are no translations available.
In this part we receive an update on exciting medical growth areas such as Dr Teneille Ludwig’s (USA) Induced Pluripotent Stem (IPS) cells lines derived from human somatic cells, newly identified stem cell in menstrual blood by Dr Julie G. Allickson (USA), diabetes, oncology, marketing and public issues.
 Moderator
Dr Marisa Jaconi, SWITZERLAND
Dr Victor Garcia, SPAIN
Dr Teneille Ludwig, WiCell Research Institute, University of Wisconsin-Madison, USA
Induced pluripotent stem cell lines derived from human somatic cells: Working to fulfill the promise – the WISC bank experience (Abstract)
Dr Marisa Jaconi and Prof. Ezio Giacobini, Unige Geneva, Switzerland
Is there a stem cell route in neurosciences?
Prof. Jacques Bernier, Radio oncologue, Clinique Genolier, Switzerland
Cancer Stem Cells Through the Lens of Radiation (Abstract)
Prof. Camillo Ricordi, Medicine Scientific Director, Diabetes Research Institute, Miami, USA
New cellular therapies for treatment of diabetes
Prof. Benoît Dubuis, President, BioAlps Association, Switzerland
Regenerative medicine in Swiss environment
Prof. Francis Bellido, Chair of Biotechnology, UQAM and Executive Chairman and COO at Alternatives Technologies Pharma, Canada
Regenerative medicine: the business perspective (Abstract)
Prof. Augusto Silva Gonzalez and Prof. Bernat Soria, General Director for Advanced Therapies of the Ministry of Health and Social Policies and Director del CABIMER (Spain)
Stem cells and public healthcare challenges
|
